Bye-law 8, National Medical Commission (Licensing of The import of drugs) Bye-laws, 2022 [SD6-ZV9]

As at 7 September 2026. In force from 15 October 2022.

In National Medical Commission (Licensing of The import of drugs) Bye-laws, 2022 [R1M-SGR]. This text from 15 October 2022. No other text held.

Synthetic. This instrument, its title, its number and the words of this section are generated by the register.

Cite: Bye-law 8, National Medical Commission (Licensing of The import of drugs) Bye-laws, 2022 [SD6-ZV9]. Machine: SD6-ZV9.

Appeal.—An appeal against an order made under these bye-laws shall be preferred by the importer of drugs aggrieved by it in Form 28 within forty-five days of the communication of the order, and shall be accompanied by a certified copy of the order appealed against, a statement of the grounds of appeal and a fee of five thousand rupees; and an appeal preferred after that period shall be accompanied by a statement of the reasons for the delay.

Defined terms in this text (0)

none

Made under this bye-law, or naming it (0)

none

Cited by (0)

none

Not held (0)

none

Duties published under this bye-law (0)

none